Wegovy - European Medicines Agency (EMA)
Wegovy is effective at reducing weight in adults with obesity or who are overweight with a weight-related health problem. It is also effective in adolescents with obesity, but there were not …
France won’t pay for weight loss drug Wegovy. What about other European …
Oct 11, 2024 · France is the latest European country to refuse to cover weight loss drugs through its national insurance programme. The anti-obesity drug Wegovy is now available in France – …
EU regulator backs use of Novo's Wegovy for obesity-related …
Sep 19, 2024 · The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on …
Novo Nordisk's Wegovy wins EU backing for reducing heart risks
Jul 26, 2024 · Novo Nordisk’s blockbuster Wegovy weight loss drug has received backing from the European Union’s medical regulator to expand the medicine’s use to include reducing the …
European regulatory authority adopts a positive opinion for an …
Bagsværd, Denmark, 25 July 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has …
Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related …
Sep 20, 2024 · Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.
Novo Nordisk A/S: Wegovy® recommended by the European
Bagsværd, Denmark, 19 September 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has …
UPDATE 2-EU drug watchdog to consider wider use of Wegovy …
Jan 22, 2024 · The European Union's drug regulator will this week consider wider use of Novo Nordisk's weight-loss drug Wegovy to include reducing the risk of strokes and heart attacks.
EU regulator backs use of Novo's Wegovy for obesity-related …
Sep 19, 2024 · (Reuters) -The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker …
EU drug watchdog to consider wider use of Wegovy weight-loss …
Jan 22, 2024 · The European Union's drug regulator will this week consider wider use of Novo Nordisk's weight-loss drug Wegovy to include reducing the risk of strokes and heart attacks.